Acute lung injury (ALI) is a severe disease caused by viral infection that triggers an uncontrolled inflammatory response. This study investigated the capacity of jasurolignoside (JO), a natural compound, to bind to Toll-like receptor 4 (TLR4) and treat ALI. The anti-inflammatory properties of JO were evaluated in vitro through Western blotting, enzyme-linked immunosorbent assay (ELISA), immunofluorescence staining, and co-immunoprecipitation. The investigation utilized a lipopolysaccharide (LPS)-induced ALI animal model to examine the therapeutic efficacy and mechanism of JO in vivo. JO attenuated inflammatory symptoms in infected cells and tissues by modulating the NOD-like receptor family pyrin domain containing protein 3 (NLRP3) inflammasome and the nuclear factor κB (NF-κB)/mitogen-activated protein kinase (MAPK) pathway. Molecular docking simulations revealed JO binding to TLR4 active sites, confirmed by cellular thermal shift assay. Surface plasmon resonance (SPR) demonstrated direct interaction between JO and TLR4 with a Kd value of 35.1 μmol·L^-1. Moreover, JO inhibited tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), and IL-6 secretion and reduced leukocyte, neutrophil, lymphocyte, and macrophage infiltration in ALI-affected mice. JO also enhanced lung function and reduced ALI-related mortality. Immunohistochemical staining demonstrated JO's ability to suppress TLR4 expression in ALI-affected mouse lung tissue. This study establishes that JO can bind to TLR4 and effectively treat ALI, indicating its potential as a therapeutic agent for clinical applications.
Toll-Like Receptor 4/chemistry* ; Animals ; Acute Lung Injury/chemically induced* ; Mice ; Humans ; Ilex/chemistry* ; Molecular Docking Simulation ; Male ; NF-kappa B/immunology* ; Mice, Inbred C57BL ; NLR Family, Pyrin Domain-Containing 3 Protein/immunology* ; Tumor Necrosis Factor-alpha/genetics* ; Interleukin-1beta/genetics* ; RAW 264.7 Cells ; Disease Models, Animal

OBJECTIVETo study the growth index and physiological index of Tianquan Bergenia purpurascens under different shade conditions (100%, 80%, 60%, 40%, 20%), and investigate its adaptation mechanism to shade environment so that it can provide theoretical basis for cultivation and production.

METHODThe growth index such as the length, the width and the number of new leaves, and leaf area, fresh weight, dry weight and specific leaf weight of the samples which were collected from the beginning of March to late May under different shade conditions were measured. The physiological index including the contents of photosynthetic pigments, MDA, soluble sugar, soluble protein, proline and the activity of SOD were measured all together.

RESULTThe growth and morphological index under light intensity 100%-60% were higher than those under light intensity 40%-20%. And except specific leaf weight, the growth and morphological index were significantly higher under light intensity 60% than those under the other shade conditions; The contents of Chla, Chlb, Chl (a + b) and Car under light intensity 100%-60% were higher than those under light intensity 40%-20%, while Chla/b was higher under light intensity 40%-20%; The activity of SOD, soluble sugar, soluble protein and proline contents were higher under light intensity 100%-60%, while MDA content was higher under light intensity 40%-20%. Chl(a+b) content, soluble sugar content and activity of SOD were the highest under light intensity 60%, but MDA content was the lowest.

CONCLUSIONSixty percent irradiance treatment was the most favorable to the growth of Tianquan B. purpurascens; 100%-80% irradiance treatments were favorable to its growth; 40%-20% irradiance treatment was negative for its growth.

Chlorophyll ; analysis ; metabolism ; Light ; Photosynthesis ; Plant Extracts ; analysis ; metabolism ; Plant Leaves ; chemistry ; growth & development ; metabolism ; radiation effects ; Saxifragaceae ; chemistry ; growth & development ; metabolism ; radiation effects

OBJECTIVE To analyze the epidemiological characteristics,the efficiency of the surveillance system for nosocomial infections in our hospital,the sensitivity,specificity and timeliness of case reporting and to evaluate the efficiencies of the monitoring and reporting system.METHODS We reviewed the nosocomial infection reporting data in the year of 2005 and identified all the reported cases,confirmed cases and under-reported cases.Sensitivity and specificity of the reporting system were calculated based on these data.RESULTS The incidence of nosocomial infection was 3.04% in 2005.A majority(72.07%) of the cases were reported within 7 days of occurrence.Respiratory tract infection accounted for 57.75% of all nosocomial infections and was by far the most common site of concern.The rates of false positive reporting ranged from 14-37% and were statistically significantly associated with the sites of the infection(P